4
Changes in Ownership
Minerva Neurosciences, Inc. Filed Acc 0001209191-17-008356
President & CEO sold 34,281 shares at an average $11.02 ($377,733)
- President & CEO acquired 34,281 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Luthringer Remy President & CEO | 2017-02-03 | Option exercise | +32,096 | $4.71 | $151,172 | 32,096 | D |
| Luthringer Remy President & CEO | 2017-02-03 | Sale | −32,096 | $11.02 | $353,698 | 0 | D |
| Luthringer Remy President & CEO | 2017-02-06 | Option exercise | +2,185 | $4.71 | $10,291 | 2,185 | D |
| Luthringer Remy President & CEO | 2017-02-06 | Sale | −2,185 | $11.00 | $24,035 | 0 | D |
| Derivatives | |||||||
| Luthringer Remy President & CEO | 2017-02-03 | Option exercise · Stock Option (Right to Buy) | −32,096 | 287,904 | D | ||
| Luthringer Remy President & CEO | 2017-02-06 | Option exercise · Stock Option (Right to Buy) | −2,185 | 285,719 | D | ||
| Open-market sales · 34,281 sh · avg $11.02 · $377,733 | |||||||
Loading xslF345X03/doc4.xml…